Protein found in yeast and humans appears to play a key role in regulating cell growth

April 13, 2000

What do humans have in common with yeast -- that lowly, single-celled organism known best for its role in making beer and bread?

Plenty, according to researchers at Seattle's Fred Hutchinson Cancer Research Center, who have found that humans and yeast share a protein that appears to play a key role in regulating cell growth.

Ronald Reeder, Ph.D., a member of the Hutchinson Center's Basic Sciences Division, heads the group that published the results of this work earlier this week in the Proceedings of the National Academy of Sciences (Early Edition No. 12). Co-authors on the paper are research associate Beth Moorefield, Ph.D., and biocomputing specialist Elizabeth Greene, Ph.D., both of the Hutchinson Center. The protein, called Rrn3, may play a pivotal role in the chain of events that determines how fast cells grow.

"For a protein to be functionally conserved from yeast all the way up to humans implies there must be a reason that it has been preserved from an evolutionary standpoint," Reeder says. "We know that if you don't have this protein, you don't grow. Even if there are other mechanisms that human cells use to regulate cell growth, the fact that this one is so well conserved in humans means it's an important piece of the puzzle in our understanding of growth control."

While Reeder and colleagues are primarily excited about this fundamental new understanding of the molecular mechanisms that trigger cell growth, the discovery that Rrn3 functions in humans as well as yeast may have several long-range benefits.

This regulatory molecule may be a unique drug target, as disabling it might halt the growth of cancer cells. The protein also might be used as a biomarker to develop highly sensitive cancer-screening methods, as the activity of Rrn3 is expected to mirror the rate of cell growth throughout the body.

"If you were looking at the thymus or the liver, for example, and wanted to distinguish cells that were doing normal things vs. cells that have lost control and gone haywire, the activity of this protein may be a very sensitive indicator of the uncontrolled cell growth characteristic of cancer," says Reeder, also an affiliate professor of zoology at the University of Washington. Because of its potential commercial applications, Reeder and colleagues have filed a patent application on the gene that produces Rrn3.

The protein appears to be a key player in an as-yet-unidentified cell-signaling pathway that results in cell growth. Reeder theorizes that Rrn3 may act as the "on" switch that instructs RNA polymerase I, the enzyme responsible for reading the genetic code, to pump out lots of ribosomal RNA, which is part of the cellular workbench that makes the proteins necessary for cell growth. The more ribosomal RNA produced, the faster the cell grows.

"Rrn3 is absolutely essential to RNA polymerase I activity," Reeder says. "When the polymerase is really active and churning out ribosomal RNA, the Rrn3 binds to it. But when the activity slows down, the Rrn3 detaches, which is why we think this protein is directly linked to a crucial cell-signaling pathway." Understanding how this pathway works in the growth of yeast will be crucial to unlocking the mystery of the process in humans.

"This finding really focuses our attention," he says. "There's a lot of machinery in the cell to study. It's all interesting, but this is one area that's really worth exploring further."

This research was funded by a grant from the National Institute of General Medical Sciences, a branch of the National Institutes of Health.
-end-
Editor's note: Copies of the paper, "RNA polymerase I transcription factor Rrn3 is functionally conserved between yeast and human," are available to reporters from the PNAS Office of News and Public Information, 202-334-2138 or at http://pnasnews@nas.edu.

The Fred Hutchinson Cancer Research Center is an independent, nonprofit research institution dedicated to the development and advancement of biomedical technology to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, the Center's four scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Hutchinson Center is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. For more information, visit the Center's Web site at http://www.fhcrc.org.

Advancing knowledge, saving lives

Fred Hutchinson Cancer Research Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.